Peripheral nerve myelin protein 22

From Citizendium
Revision as of 14:16, 31 January 2010 by imported>Howard C. Berkowitz (New page: {{subpages}} '''Peripheral nerve myelin protein 22 (PMP22)''' is clinically significant in several genetic peripheral neuropathies. In [[Charcot-Marie-Tooth disea...)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigation Jump to search
This article is developing and not approved.
Main Article
Discussion
Related Articles  [?]
Bibliography  [?]
External Links  [?]
Citable Version  [?]
 
This editable Main Article is under development and subject to a disclaimer.

Peripheral nerve myelin protein 22 (PMP22) is clinically significant in several genetic peripheral neuropathies. In Charcot-Marie-Tooth disease, the PMP22 gene is duplicated; in hereditary neuropathy with sensitivity to pressure palsies (HBPP), the gene is omitted.

In hereditary motor and sensory neuropathy type 1a (HMSN1a), the level of anti-PMP22 antibody indicated a trend toward the progression of disease. [1]

References

  1. Gabriel CM, Gregson NA, Wood NW, Hughes RAC (2002), "Immunological study of hereditary motor and sensory neuropathy type 1a (HMSN1a)", J Neurol Neurosurg Psychiatry 72: 230-235, DOI:10.1136/jnnp.72.2.230